FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to a method for predicting the clinical course of type 2 diabetes mellitus using an oral glucose-lowering therapy based on assessing the variability of glycemia. Method comprises daily monitoring of blood glucose 7 time points for 3 days, calculating average during observation coefficient of variation (CV) of glycemia and if value of CV<30 % predicting favorable course of type 2 diabetes mellitus and positive effect of therapy, and with CV>30 % prediction of unstable clinical course of diabetes mellitus and high risk of hypoglycemic conditions.
EFFECT: method provides a quantitative assessment in order to increase its accuracy, wider range of means for assessing the course of the disease and the effectiveness of the therapy in patients suffering type 2 diabetes mellitus.
1 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING GLYCEMIC VARIABILITY TO DETERMINE EFFECTIVENESS OF ANTIHYPERGLYCEMIC THERAPY IN PATIENTS WITH MODY2 DIABETES | 2020 |
|
RU2746830C1 |
METHOD FOR CARDIOVASCULAR COMPLICATIONS PREDICTION AFTER CORONARY BYPASS SURGERY FOR PATIENTS WITH TYPE 2 DIABETES | 2015 |
|
RU2620680C1 |
METHOD FOR DETERMINATION TYPE 1 DIABETES COMPENSATION FOR ADOLESCENTS | 2015 |
|
RU2613272C1 |
METHOD OF TREATING DIABETES MELLITUS IN OUTCOME OF TOTAL DUODENOPANCREATECTOMY | 2023 |
|
RU2823874C1 |
METHOD OF TREATING DIABETES MELLITUS AND COMBINED MEDICATION | 2013 |
|
RU2565401C2 |
METHOD FOR PREDICTING THE EFFECTIVENESS OF THERAPY USING ORAL HYPOGLYCEMIC AGENT METFORMIN IN PATIENTS WITH TYPE 2 DIABETES | 2015 |
|
RU2602663C1 |
METHOD FOR PREDICTION OF RISK OF LIFE-THREATENING ARRHYTHMIAS IN CHILDREN WITH TYPE 1 DIABETES MELLITUS | 2019 |
|
RU2707050C1 |
METHOD FOR PREDICTION OF IMPROVEMENT OF LEFT VENTRICULAR DIASTOLIC FUNCTION IN 6 MONTHS AFTER PROCEDURE OF SYMPATHETIC DENERVATION OF RENAL ARTERIES IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS | 2023 |
|
RU2817191C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE AND TREATMENT EFFICACY OF TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2533286C1 |
DRUG FOR REDUCING INSULIN RESISTANCE AND FOR TREATING DIABETES, METHOD OF REDUCING INSULIN RESISTANCE, METHOD OF TREATING DIABETES AND METHOD OF TREATING DIABETES WITH INSULIN AND/OR HYPOGLYCEMIC PREPARATIONS | 2011 |
|
RU2509572C2 |
Authors
Dates
2020-06-17—Published
2019-12-17—Filed